Published in BMC Endocr Disord on June 29, 2004
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2006) 1.42
Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas. Oncologist (2013) 0.97
Clinical experiences of pheochromocytoma in Korea. Yonsei Med J (2011) 0.91
Advances in biochemical screening for phaeochromocytoma using biogenic amines. Clin Biochem Rev (2009) 0.87
Measurement of fractionated plasma metanephrines for exclusion of pheochromocytoma: Can specificity be improved by adjustment for age? BMC Endocr Disord (2005) 0.84
A patient with a large recurrent pheochromocytoma demonstrating the pitfalls of diagnosis. Nat Rev Endocrinol (2011) 0.83
The role of urinary fractionated metanephrines in the diagnosis of phaeochromocytoma. Indian J Med Res (2013) 0.78
Endocrine hypertension: An overview on the current etiopathogenesis and management options. World J Hypertens (2015) 0.75
Management of Adrenal Masses. Indian J Surg Oncol (2016) 0.75
Plasma Methoxytyramine: Clinical Utility with Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma. Eur J Endocrinol (2017) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Empirical evidence of design-related bias in studies of diagnostic tests. JAMA (1999) 12.96
The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med (2003) 10.28
Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ (2001) 9.63
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med (2003) 8.58
Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med (2002) 6.94
Biochemical diagnosis of pheochromocytoma: which test is best? JAMA (2002) 4.84
A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab (2003) 3.25
Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. Am J Epidemiol (1999) 2.59
Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. Int J Epidemiol (2002) 2.49
Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med (2001) 2.45
Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc (1983) 2.01
Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. J Clin Endocrinol Metab (2001) 1.91
The urinary metanephrine-to-creatinine ratio for the diagnosis of pheochromocytoma. Ann Intern Med (1996) 1.87
Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am (2000) 1.81
Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med (1999) 1.65
Assessing the gain in diagnostic performance when combining two diagnostic tests. Stat Med (2002) 1.65
Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med (1995) 1.64
Pheochromocytoma: 1926-1993. Trends Endocrinol Metab (2008) 1.50
Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications. N Engl J Med (1979) 1.49
Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev (1994) 1.48
Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clin Chem (1993) 1.47
The incidence rate of phaeochromocytoma and Conn's syndrome in Denmark, 1977-1981. J Hum Hypertens (1988) 1.45
6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension (2001) 1.45
Pheochromocytoma in Sweden 1958-1981. An analysis of the National Cancer Registry Data. Acta Med Scand (1986) 1.39
Sensitivity of diagnostic and localization tests for pheochromocytoma in clinical practice. Arch Intern Med (2000) 1.39
Pheochromocytoma in Italy: a multicentric retrospective study. Eur J Endocrinol (1999) 1.38
Pheochromocytoma. Endocrinol Metab Clin North Am (1994) 1.35
Adrenocorticotropic hormone-secreting pheochromocytomas: the exception to the rule. Surgery (1995) 1.29
Disappearance rate of catecholamines, total metanephrines, and neuropeptide Y from the plasma of patients after resection of pheochromocytoma. Clin Chem (2001) 1.27
Systematic reviews to evaluate diagnostic tests. Eur J Obstet Gynecol Reprod Biol (2001) 1.26
Quantification of unconjugated metanephrines in human plasma without interference by acetaminophen. Clin Chem (2001) 1.20
Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma. Arch Intern Med (2000) 1.16
Pheochromocytoma. J Clin Hypertens (Greenwich) (2002) 1.15
Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma. Medicine (Baltimore) (1991) 1.14
Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocrinol Metab (1998) 1.05
Pheochromocytoma: clinical manifestations and diagnostic tests. Urology (1981) 1.03
Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines. J Clin Endocrinol Metab (1995) 1.03
Biochemical tests for diagnosis of phaeochromocytoma: urinary versus plasma determinations. Br Med J (Clin Res Ed) (1981) 1.03
Diagnostic evaluation of pheochromocytoma. Endocrinol Metab Clin North Am (1988) 1.01
Diagnosis of pheochromocytoma. Clin Lab (2002) 0.94
New advances in the biochemical diagnosis of pheochromocytoma: moving beyond catecholamines. Ann N Y Acad Sci (2002) 0.94
Measurement of plasma free metanephrine and normetanephrine by liquid chromatography-tandem mass spectrometry for diagnosis of pheochromocytoma. Clin Chem (2004) 0.93
Spells: in search of a cause. Mayo Clin Proc (1995) 0.92
Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study. Eur J Endocrinol (2001) 0.92
Glucagon and clonidine testing in the diagnosis of pheochromocytoma. Hypertension (1991) 0.91
The predictive value of diagnostic tests for pheochromocytoma. Surgery (1994) 0.90
Utility of plasma free metanephrines for detecting childhood pheochromocytoma. J Clin Endocrinol Metab (2002) 0.90
Chromogranin A assay and (131)I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma. J Nucl Med (2001) 0.90
[Recent progress in the diagnosis, prognostic evaluation and treatment of pheochromocytomas]. Rev Med Interne (2000) 0.89
A "pheo" lurks: novel approaches for locating occult pheochromocytoma. J Clin Endocrinol Metab (2001) 0.89
Validation of liquid chromatography-tandem mass spectrometry method for analysis of urinary conjugated metanephrine and normetanephrine for screening of pheochromocytoma. Clin Chem (2002) 0.89
Phaeochromocytoma in Queensland--1970-83. Aust N Z J Surg (1985) 0.88
Efficacy of single-voided urine metanephrine and normetanephrine assay for diagnosing pheochromocytoma. World J Surg (1998) 0.87
Management approaches to adrenal incidentalomas (adrenalomas). A view from Athens, Greece. Endocrinol Metab Clin North Am (2000) 0.87
[Diagnostic and therapeutic strategy for an incidental finding of an adrenal mass]. J Chir (Paris) (2002) 0.87
Urinary and plasma catecholamines and urinary catecholamine metabolites in pheochromocytoma: diagnostic value in 19 cases. Clin Chem (1994) 0.87
Single-voided urine metanephrine assays in screening for pheochromocytoma. Arch Intern Med (1977) 0.86
Overnight excretion of urinary catecholamines and metabolites in the detection of pheochromocytoma. J Clin Endocrinol Metab (1996) 0.86
Incidence of pheochromocytoma in South Galicia, Spain. J Intern Med (1994) 0.84
Laboratory diagnosis of phaeochromocytoma: which analytes should we measure? Ann Clin Biochem (1993) 0.84
[Detection, diagnosis and localization of pheochromocytoma. 77 cases in a population of 21,420 hypertensive patients]. Presse Med (1987) 0.84
Localization of medullary thyroid carcinoma metastasis in a multiple endocrine neoplasia type 2A patient by 6-[18F]-fluorodopamine positron emission tomography. J Clin Endocrinol Metab (2003) 0.83
Pheochromocytoma and primary aldosteronism. Cancer Treat Res (1997) 0.83
Plasma metadrenalines: do they provide useful information about sympatho-adrenal function and catecholamine metabolism? Clin Sci (Lond) (1995) 0.83
Adrenal incidentaloma. Braz J Med Biol Res (2000) 0.82
Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas. J Clin Endocrinol Metab (2000) 0.82
[Biochemical diagnosis of pheochromocytoma by determining normetanephrine and metanephrine concentrations in single voided urine]. Nihon Naibunpi Gakkai Zasshi (1988) 0.81
Phaeochromocytoma and paraganglioma. Baillieres Clin Endocrinol Metab (1993) 0.81
[Biochemical diagnosis of pheochromocytoma and neuroblastomas]. Ann Biol Clin (Paris) (2002) 0.81
Editorial: biochemical diagnosis of pheochromocytoma--is it time to switch to plasma-free metanephrines? J Clin Endocrinol Metab (2003) 0.81
Plasma adrenomedullin concentrations in patients with adrenal pheochromocytoma. Horm Metab Res (2001) 0.81
REPCAT: desktop expert system for interpreting and validating laboratory data for pheochromocytoma diagnosis with the database application Omnis 7. Clin Chem (1997) 0.80
Choice of biochemical test for diagnosis of pheochromocytoma: validation of plasma metanephrines. Curr Hypertens Rep (2002) 0.80
Posttraumatic hypertension secondary to adrenal hemorrhage mimicking pheochromocytoma: case report. J Trauma (1999) 0.80
Evaluation of specific high-performance liquid-chromatographic determinations of urinary metanephrine and normetanephrine by comparison with isotope dilution mass spectrometry. Ann Clin Biochem (2001) 0.79
Lessons from an unpleasant surprise: a biochemical strategy for the diagnosis of pheochromocytoma. J Hypertens (2001) 0.79
Acromegaly and pheochromocytoma: report of a rare coexistence. Endocr Pract (2002) 0.79
Plasma and 24 h-urinary catecholamine concentrations in normal and patient populations. Ann Clin Biochem (1993) 0.79
Adrenocorticotropic hormone-secreting pheochromocytoma. Intern Med (1998) 0.79
Plasma metanephrines: a novel and cost-effective test for pheochromocytoma. Braz J Med Biol Res (2000) 0.79
The meta-analysis of diagnostic test studies. Eur Radiol (1998) 0.78
Biochemical diagnosis of phaeochromocytoma: two instructive case reports. J Clin Pathol (1993) 0.78
Pheochromocytoma and primary aldosteronism: diagnostic approaches. Endocrinol Metab Clin North Am (1997) 0.78
How to detect pheochromocytomas?--the diagnostic relevance of plasma free metanephrines. Wien Klin Wochenschr (2002) 0.77
[Extra-adrenal pheochromocytoma. Report of a case]. Arch Esp Urol (2000) 0.76
[Pheochromocytoma. The risk to miss diagnosis of severe disease is reduced when free metanephrines are measured in plasma]. Lakartidningen (1998) 0.76
Brain uptake of iodine-131 metaiodobenzylguanidine following therapy of malignant pheochromocytoma. Clin Nucl Med (1998) 0.76
Medical allowable imprecision in measuring urinary metanephrines. Clin Biochem (2001) 0.76
[Plasma metanephrine measurements make the diagnosis of pheochromocytoma easier]. Lakartidningen (1998) 0.76
[Pheochromocytoma]. Rev Prat (1998) 0.76
[Usefulness of the clonidine test for the diagnosis of pheochromocytoma]. Rev Clin Esp (2001) 0.76
Pheochromocytoma in a patient with end-stage renal disease. Mayo Clin Proc (2001) 0.76
Plasma metanephrines in the diagnosis of pheochromocytoma. Ann Intern Med (1996) 0.76
[The nephrotic syndrome and pheochromocytoma. A report of a rare clinical case]. Clin Ter (1994) 0.76
Incidentally discovered adrenal masses: a functional and morphological study. Exp Clin Endocrinol (1993) 0.76
[Advances in diagnostic procedures for detection of pheochromocytoma]. Rinsho Byori (1993) 0.76
Statistics in the pathology laboratory: diagnostic test interpretation. Pathology (2002) 0.76
Measurement of plasma methoxyamines for the diagnosis of pheochromocytoma. Horm Res (1991) 0.76
Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet (2010) 12.92
Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA (2006) 11.71
Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med (2015) 7.83
Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med (2014) 6.65
Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2008) 6.48
What matters most in end-of-life care: perceptions of seriously ill patients and their family members. CMAJ (2006) 5.70
Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology (2013) 5.69
A randomized trial of planned cesarean or vaginal delivery for twin pregnancy. N Engl J Med (2013) 5.06
Less-tight versus tight control of hypertension in pregnancy. N Engl J Med (2015) 5.03
Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA (2012) 4.58
Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: a randomized trial. JAMA (2004) 4.18
Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med (2008) 4.03
Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med (2014) 3.96
Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ (2011) 3.81
Femoral nerve block improves analgesia outcomes after total knee arthroplasty: a meta-analysis of randomized controlled trials. Anesthesiology (2010) 3.42
Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet (2008) 3.41
A model to determine workforce needs for endocrinologists in the United States until 2020. J Clin Endocrinol Metab (2003) 3.38
A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab (2003) 3.25
Quality of life of individuals with heart failure: a randomized trial of the effectiveness of two models of hospital-to-home transition. Med Care (2002) 3.05
The safety of long-acting beta-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis. Am J Respir Crit Care Med (2008) 3.01
Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab (2004) 2.86
Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med (2007) 2.82
Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid (2009) 2.79
Requirements for physicians in 2030: why population aging matters less than you may think. CMAJ (2003) 2.73
An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension (2013) 2.72
Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2014) 2.72
Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ (2009) 2.64
Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women. Am J Med (2009) 2.64
Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial. CMAJ (2009) 2.58
Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab (2004) 2.56
Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer. J Natl Cancer Inst (2003) 2.51
Effectiveness of home visitation by public-health nurses in prevention of the recurrence of child physical abuse and neglect: a randomised controlled trial. Lancet (2005) 2.46
Application of data mining techniques in pharmacovigilance. Br J Clin Pharmacol (2004) 2.32
Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol (2008) 2.31
A shared treatment decision-making approach between patients with chronic conditions and their clinicians: the case of diabetes. Health Expect (2006) 2.30
Outcomes of children at 2 years after planned cesarean birth versus planned vaginal birth for breech presentation at term: the International Randomized Term Breech Trial. Am J Obstet Gynecol (2004) 2.26
Treatment decision aids: conceptual issues and future directions. Health Expect (2005) 2.25
Are cancer-related decision aids effective? A systematic review and meta-analysis. J Clin Oncol (2009) 2.24
Quality of reporting of randomized controlled trials in general endocrinology literature. J Clin Endocrinol Metab (2008) 2.24
Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer (2004) 2.20
Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5). JAMA Pediatr (2013) 2.18
The efficacy of botulinum toxin type A in managing chronic musculoskeletal pain: a systematic review and meta analysis. Inflammopharmacology (2010) 2.11
Effect on birth outcomes of a formalised approach to care in hospital labour assessment units: international, randomised controlled trial. BMJ (2008) 2.11
Economists' dream or nightmare? Maximizing health gains from available resources using the NICE guidelines. Health Econ Policy Law (2007) 2.06
The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS One (2012) 2.05
Meta-analysis: cardiovascular events associated with nonsteroidal anti-inflammatory drugs. Am J Med (2006) 2.02
The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study. PLoS One (2011) 2.02
Optimizing a portfolio of health care programs in the presence of uncertainty and constrained resources. Soc Sci Med (2003) 2.01
Alternatives to project-specific consent for access to personal information for health research: what is the opinion of the Canadian public? J Am Med Inform Assoc (2007) 1.98
Shared treatment decision making: what does it mean to physicians? J Clin Oncol (2003) 1.97
Mediastinal paragangliomas: the mayo clinic experience. Ann Thorac Surg (2008) 1.95
A systematic review and meta-analysis of studies using the STRATIFY tool for prediction of falls in hospital patients: how well does it work? Age Ageing (2008) 1.94
Effectiveness of nurses as providers of birth labor support in North American hospitals: a randomized controlled trial. JAMA (2002) 1.94
The HAART cell phone adherence trial (WelTel Kenya1): a randomized controlled trial protocol. Trials (2009) 1.92
Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health (2007) 1.86
Maternal outcomes at 2 years after planned cesarean section versus planned vaginal birth for breech presentation at term: the international randomized Term Breech Trial. Am J Obstet Gynecol (2004) 1.83
Views on health information sharing and privacy from primary care practices using electronic medical records. Int J Med Inform (2010) 1.83
Male involvement in prevention programs of mother to child transmission of HIV: a systematic review to identify barriers and facilitators. Syst Rev (2013) 1.82
Hypotonic versus isotonic maintenance fluids after surgery for children: a randomized controlled trial. Pediatrics (2011) 1.82
Gabapentin does not improve multimodal analgesia outcomes for total knee arthroplasty: a randomized controlled trial. Can J Anaesth (2013) 1.80
Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision. J Clin Oncol (2004) 1.80
Cervical spondylotic myelopathy: a brief review of its pathophysiology, clinical course, and diagnosis. Neurosurgery (2007) 1.76
Conceptualizing and validating the human services integration measure. Int J Integr Care (2004) 1.75
Bilateral laparoscopic adrenalectomy for corticotrophin-dependent Cushing's syndrome: a review of the Mayo Clinic experience. Clin Endocrinol (Oxf) (2007) 1.75
Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Pract Nephrol (2006) 1.72
Hospital and home chemotherapy for children with leukemia: a randomized cross-over study. Pediatr Blood Cancer (2006) 1.72
The risks of waiting for cardiac catheterization: a prospective study. CMAJ (2002) 1.70
Pituitary carcinoma: a clinicopathological review. Neurosurgery (2005) 1.70
Clinical review 164: The laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. J Clin Endocrinol Metab (2003) 1.68
Self-reported use of shared decision-making among breast cancer specialists and perceived barriers and facilitators to implementing this approach. Health Expect (2004) 1.67
Mobile phone text messages for improving adherence to antiretroviral therapy (ART): an individual patient data meta-analysis of randomised trials. BMJ Open (2013) 1.66
Exercise for improving outcomes after osteoporotic vertebral fracture. Cochrane Database Syst Rev (2013) 1.63
Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs. J Affect Disord (2002) 1.63
Association between framing of the research question using the PICOT format and reporting quality of randomized controlled trials. BMC Med Res Methodol (2010) 1.63
Plasma chromogranin A or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytoma. J Clin Endocrinol Metab (2007) 1.60
Pregnancy outcomes in women with chronic kidney disease: a systematic review. Clin J Am Soc Nephrol (2011) 1.59
A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism. J Hypertens (2011) 1.57
Sex differences in hospital admissions from emergency departments in asthmatic adults: a population-based study. Ann Allergy Asthma Immunol (2006) 1.57
Outcomes at 3 months after planned cesarean vs planned vaginal delivery for breech presentation at term: the international randomized Term Breech Trial. JAMA (2002) 1.56
Features predicting the success of computerized decision support for prescribing: a systematic review of randomized controlled trials. BMC Med Inform Decis Mak (2009) 1.55
Exploring the effects of population change on the costs of physician services. J Health Econ (2002) 1.55
Assessment of the quality and variability of health information on chronic pain websites using the DISCERN instrument. BMC Med (2010) 1.55
Dexamethasone-suppressed corticotropin-releasing hormone stimulation test for diagnosis of mild hypercortisolism. J Clin Endocrinol Metab (2007) 1.54
Shared decision making in the medical encounter: are we all talking about the same thing? Med Decis Making (2007) 1.53
Understanding cardiopulmonary resuscitation decision making: perspectives of seriously ill hospitalized patients and family members. Chest (2006) 1.53
"Sleepiness" is serious in adolescence: two surveys of 3235 Canadian students. BMC Public Health (2006) 1.53
Gamma knife radiosurgery for patients with prolactin-secreting pituitary adenomas. World Neurosurg (2010) 1.49
The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy. Can J Cardiol (2002) 1.49
Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res (2006) 1.48
Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology (2014) 1.47
The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy. Can J Cardiol (2004) 1.46
Shared decision-making in primary care: tailoring the Charles et al. model to fit the context of general practice. Patient Educ Couns (2005) 1.46
Preferences for evidence-based practice dissemination in addiction agencies serving women: a discrete-choice conjoint experiment. Addiction (2012) 1.45
Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center. Pediatrics (2006) 1.45
An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer. Endocrinol Metab Clin North Am (2008) 1.44
Sample sizes for clinical trials using sputum eosinophils as a primary outcome. Eur Respir J (2013) 1.42